New Acer H6535i Delivers Wireless, Affordable 1080p Home Theater


https://www.prweb.com/

The Acer H6535i wirelessly projects movies and photos from an Android, IOS or Windows 10 device.

“Priced affordably, our newest projector lets more people experience the thrill of enjoying movies and more on a big screen from the comfort of home,” said Ronald Lau, Acer America director – stationary products.

Acer America announced its Acer H6535i home entertainment projector is now available in the United States. This new model offers wireless projection of movies, games and photos in Full HD to a big screen for an affordable price of $699.99 MSRP.

This DLP® LED projector with HDMI input can project a giant 25 foot image from a distance of up to 36 feet with a high 3,500 lumens brightness. Paired with a wireless dongle(2), it projects content wirelessly from a smartphone or PC. Miracast(3) support allows quick and seamless screen mirroring without installing an extra app. HDMI, VGA and USB ports connect to Android(3) devices for easily sharing travel photos or home videos.

“Priced affordably, our newest projector lets more people experience the thrill of enjoying movies and more on a big screen from the comfort of home,” said Ronald Lau, Acer America director – stationary products. “It’s bright enough for projecting content in ambient light and works wirelessly with a variety of devices.”

The 20,000:1 contrast ratio delivers vivid images. Even dark scenes are clearly displayed with no loss of detail thanks to DynamicBlack™ technology, which improves image contrast by analyzing on-screen content frame-by-frame, then dynamically adjusting lamp power to optimize black levels. A 1.2X zoom ratio maximizes positioning options for the projector, while four corner correction quickly and easily adjusts corners to eliminate distortion.

Integrated ColorBoost3D technology features an optimized 6-segment color wheel, advanced lamp illumination and powerful image processing to deliver excellent color reproduction and saturation without sacrificing brightness. In addition, ColorSafe II prevents color decay even after thousands of hours of use. To help prevent eye fatigue, the Acer H6535i has Acer BlueLightShield, an adjustable filter to reduce blue light emissions up to 30 percent. It features three filter levels to accommodate different usage scenarios.

The Acer H6535i delivers a good return on investment with a long product lifespan of up to 10,000 hours in ECO mode(4) and up to 15,000 hours in ExtremeECO mode. It’s also outfitted with a 2W speaker and comes with a remote control.(5)

Pricing/Availability

The Acer H6535i home entertainment projector is available at online retailers in the United States for $699.99 (MSRP). It comes with a limited one-year parts and labor warranty (6).

Editor’s Summary

  • Affordable projector for wirelessly projecting movies and photos from an Android(1), IOS or Windows 10 device(2)
  • High 3,500 ANSI lumens delivers a huge, clear and bright picture – up to 25 feet – even during daylight
  • Delivers sharp 1080p Full HD visuals with natural color

About Acer

Founded in 1976, Acer is now one of the world’s top ICT companies and has a presence in over 160 countries. As Acer looks into the future, it is focused on enabling a world where hardware, software and services will fuse with one another to open up new possibilities for consumers and businesses alike. From service-oriented technologies to the Internet of Things to gaming and virtual reality, Acer’s 7,000+ employees are dedicated to the research, design, marketing, sale, and support of products and solutions that break barriers between people and technology. Please visit http://www.acer.com for more information.

Media Contact

Erin Davern

Tel: +949-471-7785

Email: erin.davern@acer.com

© 2019 Acer America Corp. All rights reserved. Acer and the Acer logo are registered trademarks of Acer Inc. Other trademarks, registered trademarks, and/or service marks, indicated or otherwise, are the property of their respective owners. All offers subject to change without notice or obligation and may not be available through all sales channels. Prices listed are manufacturer suggested retail prices and may vary by location. Applicable sales tax extra.

1) Android 5.0 & above

2) Wireless dongle is required for wireless projection.

3) Additional device must support Miracast technology.

4) Lamp life depends on a variety of factors including brightness and can be maximized via Acer EcoProjection Technology, which allows the user to customize power-saving configurations.

5) Two AAA batteries required for the remote control are not included.

6) Limited warranty agreement applies. For a copy, write to Acer Customer Service, P.O. Box 6137, Temple, TX 76503.

Share article on social media or email:

ZENB Expands Its Veggie Stick Line With New Pumpkin And Carrot Flavors


We are thrilled to introduce our new Pumpkin and Carrot flavors to consumers just in time for the fall season

ZENB, a plant-based food company that launched earlier this year, today announced the roll out of two new flavors in its Veggie Stick product line: Pumpkin and Carrot. The savory, fall-inspired Veggie Sticks bring ZENB fans a total of five flavor options as the company continues to innovate new ways to deliver wholesome vegetables in convenient snacking options.

The new Veggie Stick flavors, available year-round, boast 3-4g of fiber, 3g of protein and are less than 150 calories each per serving. By using organic, whole vegetables, ZENB’s Veggie Sticks offer a good source of daily fiber and clean ingredients in every Stick. As part of a commitment to using whole, fiber-rich vegetables, ZENB also incorporates parts of the vegetables that are often thrown away, like the seeds of the pumpkin and peel of the carrot. Thanks to a rigorous sourcing and manufacturing process, ZENB’s Veggie Sticks are gluten-free, vegan, and USDA organic, and offer consumers a clean label option for any occasion.

“We are thrilled to introduce our new Pumpkin and Carrot flavors to consumers just in time for the fall season. These flavors are sure to appeal with their savory taste profiles, colorful appearance and ode to the season,” says Christiane Paul, CMO of ZENB. “Moving forward, our commitment is to not only develop more Veggie Stick flavors like these, but also to provide a comprehensive line of plant-based, delicious products that fit into multiple dining occasions.”

Each Veggie Stick flavor offers a unique taste profile for an elevated snacking experience. Using the whole pumpkin, including skin and seeds, Pumpkin Veggie Sticks offer full-flavored veggie taste with a touch of cinnamon & nutmeg that’s perfect for the fall but can be enjoyed all year long. For on-the-go fiber and nutrition, the Carrot Veggie Sticks, made with the whole carrot, including the skin, offer the taste of organically grown carrots with a hint of flavorful coriander.

ZENB’s Veggie Sticks come in five distinct flavors: Corn, Beet, Red Bell Pepper, Carrot and Pumpkin. They are available all year direct-to-consumer via single sale and subscription boxes on ZENB.com, starting at $17.99 for a box of six. ZENB also offers a free trial pack (plus $4.99 shipping & handling and applicable tax) for veggie-lovers to try multiple flavors. Subject to terms and conditions, please see ZENB.com for more information.

About ZENB

ZENB is changing the way consumers think about nutrition by placing food that is wholesome and delicious at the center of everyday lives. By offering products that use often discarded parts of vegetables in each product, ZENB helps consumers enjoy plant-based foods in a way that is more mindful of the world around us. The company’s debut product, ZENB Veggie Sticks, are just the beginning of ZENB’s vision to empower a wholesome lifestyle filled with delicious, convenient options that incorporates a more plant-based diet. For more information about the ZENB community and product offerings, visit us at http://www.ZENB.com.

Share article on social media or email:

A ‘New Dawn’ in Treating Early Osteoarthritis of the Basal Joint


https://www.prweb.com/

Dr. Alejandro Badia

Until now, effective treatments for stopping the progression of osteoarthritis have been limited but increasing studies of the biological basis of the disorder are leading to new therapies, including application of protease inhibitors.

Scientists writing in a 2017 issue of European Medical Journal predicted that new, more effective therapeutic agents to stop the progressive destruction of joint cartilage in osteoarthritis are “on the close horizon.” Well, that day may already have dawned, says Miami-based hand and upper limb orthopedic surgeon Alejandro Badia, MD, founder and chief medical officer of the Badia Hand to Shoulder Center and OrthoNOW®, who is using advanced techniques, including natural biomaterials, to treat osteoarthritis of the thumb.

An expert in orthobiologics, Dr. Badia is harnessing the power of protease inhibitors to slow, and potentially halt, destruction of joint cartilage in the basal — carpometacarpal (CMC) – joint at the base of the thumb in patients with early osteoarthritis of the hand.

Orthobiologics involves utilizing a patient’s own biologic substances, or those of a donor, including blood platelets (PRP therapy) and adult (mesenchymal) stem cells, to mitigate inflammation, relieve chronic musculoskeletal pain and repair orthopedic injuries.

Dr. Badia explains that inflammation is a response to age-related wear-and-tear or injury to a joint and is believed to support the transition to pathological osteoarthritis. Although many factors can contribute to the development of osteoarthritis, nobody knows the primary cause of the debilitating disease. Many sedentary people develop this as they age, and both occupational and genetic factors play a part. It is certain however that repetitive and acute injuries, if untreated, will worsen the symptoms of underlying arthritis and accelerate its development and progression.

Researchers have determined that cartilage degradation is accelerated by chronic inflammation through the excessive activity of proteases, enzymes that normally function to clear damaged tissue after an injury but when they persist in chronically-inflamed joints they lead to degradation of cartilage and subsequent joint pain. Cartilage serves as a cushion for joints; its breakdown leads to joint stiffness and pain, Dr. Badia explains. Proteases are vital to many biological functions, such as digestion and cellular repair, but over-activity of these enzymes in the joint can speed the degradation of cartilage’s extracellular matrix.

But, protease inhibitors, like alpha 1-antitrypsin and alpha 2-macroglobulin, are molecules that can be harvested from blood plasma and other tissues to inhibit inflammatory proteases and clear them from the joint.

“Injection of these inhibitors into the basal joint is proving successful in some patients for relieving the debilitating pain of osteoarthritis of the thumb and potentially helping rebuild some of the lost cartilage,” says Dr. Badia. He and his team at OrthoNOW have treated arthritic patients using a variety of advanced surgical, non-surgical and orthobiologic approaches.

Osteoarthritis is the most common joint disease overall. Basal joint osteoarthritis, a specific form of the disorder, is the second most common arthritic condition of the hand, Dr. Badia says. The thumb disorder can result in severe pain, loss of grip function, strength and restricted range of motion and even deformity – to the point where a patient has difficulty holding a can or glass, opening a jar lid or buttoning a shirt, Dr. Badia notes.

Until now, effective treatments for stopping the progression of osteoarthritis have been limited but increasing studies of the biological basis of the disorder are leading to new therapies, including application of protease inhibitors.

Dr. Badia credits scientists like Shawn Browning Ph.D., vice president of research and development at Holding Technologies, who has studied the biology of joint cartilage degeneration in osteoarthritis, and medical innovators, such as Ziad Hamandi, chief executive officer of ABT Medical, for progress in treating osteoarthritis with protease inhibitors and other orthobiologics. Under Hamandi’s leadership, ABT Medical and their physician collaborators have designed advanced processes for separating blood and other fluid biologics into needed therapeutic components.

“The mission ABT Medical is to be innovative in the development of comprehensive blood management programs that are both responsive and reliable,” Hamandi states.

Orthobiologic therapies are not without risk, according to the federal Food and Drug Administration (FDA). Side effects can include reactions at site of injection, failure of biomaterials to perform as intended, and migration of injected cells away from treatment areas, potentially changing into unwanted cell types, multiplying, and negatively affecting other tissues.

Dr. Badia advises caregivers to exercise caution when administering biomaterials and exhorts patients to be especially careful when seeking medical help in the area of orthobiologics, a specialization in which practitioners often lack necessary training and expertise. It is imperative for patients who are considering regenerative medicine options to seek a clinician who can offer multiple remedies and solutions depending on the patient’s needs and stage of disease. In many cases, clinicians who have stem cell clinics are limited in what they can offer. OrthoNOW provides autologous access to stem cell therapies as well as other conservative therapies that the patient may benefit from, including anti-inflammatory mediators, physical therapy, procedures such as a joint arthroscopy, or even joint replacement for more severe cases. Dr. Badia worries that sometimes patients are being misled by practitioners who are not fully qualified to do regenerative medicine.

“Better than the best therapies for osteoarthritis, of course, is prevention,” states Dr. Badia. “You cannot stop joints from growing older, but you can reduce your risk for joint problems.” He offers the following recommendations:

  • Maintain an appropriate weight.
  • Keep joints heathy through exercise.
  • Control blood sugar.
  • Avoid joint injuries by wearing the proper protective gear when engaged in sports.

See an orthopedic specialist as soon as possible for diagnosis and treatment if a joint injury fails to heal. Injured joints are seven times more likely to develop osteoarthritis, according to the Arthritis Foundation.

Bio: Alejandro Badia, MD, FACS, internationally renowned hand and upper-limb surgeon and founder of Badia Hand to Shoulder Center and OrthoNOW®, a walk-in orthopedic care clinic. He is a member the American Society for Surgery of the Hand, American Association for Hand Surgery, and the American Academy of Orthopedic Surgeons. He is a specialist in treating all problems related to the hand and upper extremity including trauma, sports injury, joint reconstruction, nerve injuries and arthroscopic surgeries. OrthoNOWcare.com and drbadia.com.

Fastest Growing Provider of Self-Directed Retirement Plans Sees High Demand for Solo 401(k) Plans


solo 401(k) for self-employed and small business owners

IRA Financial, leading provider of Self-Directed Retirement plans, surpasses 6,000 Solo 401(k) Plan Clients

I have written two books on the self-directed solo 401(k) plan and believe it is the most robust retirement plan for the self-employed or small business owner with no full-time employees

IRA Financial Group & IRA Financial Trust Company (“IRA Financial”), a leading financial technology Self-Directed IRA and Solo 401(k) plan provider & custodian, announces that is has surpassed 6,000 self-directed Solo 401(k) plans, believed to be the most in the country.

“I have written two books on the self-directed solo 401(k) plan and believe it is the most robust retirement plan for the self-employed or small business owner with no full-time employees,” says Adam Bergman, President of IRA Financial Group & IRA Financial Trust Company.

The Solo 401(k) structure, also known as the one-participant plan, allows business owners to invest in traditional as well as alternative asset investments, such as real estate, tax liens and cryptocurrency. The plan also allows participants to make higher contributions (up to $62,000 in pre-tax, after-tax, or Roth) and borrow up to $50,000 tax and penalty free.

“IRA Financial’s Solo 401(k) plan is 100% open architecture and self-directed,” explains Mr. Bergman. “IRA Financial handles all plan IRS administration for one low annual fee.”

IRA Financial, one of the country’s fastest growing providers of Self-Directed retirement plans, has helped over 16,000 clients invest over $4.5 billion in retirement funds in alternative assets through its self-directed IRA and self-directed solo 401(k) plans. IRA Financial has also developed the first mobile app in the self-directed marketplace that allows clients to be onboarded and invest in alternative asset investments 100% digitally.

IRA Financial Group & IRA Financial Trust Company offers the Self-Directed IRA and Solo 401(k) plan platform, which allows investors to invest in IRS approved alternative asset investments digitally and with no account valuation or minimum balance fees. The primary advantage of using a self-directed solo 401(k) plan to make private IRS approved alternative asset investments, is that one can diversify their retirement assets and invest in what one knows and trusts. In addition, with a self-directed solo 401(k) plan generally all income and gains associated with the retirement account investment grow tax-deferred or tax-free in the case of a Roth solo 401(k).

“We continue to see huge demand for the self-directed solo 401(k) plan because of the multitude of exciting retirement and investment options it offers,” stated Mr. Bergman.

IRA Financial Group is the market’s fastest growing provider of self-directed retirement plans. IRA Financial Group has helped over 16,000 thousand clients take back control over their retirement funds while gaining the ability to invest in almost any type of investment, including real estate, cryptocurrency, and private business investments.

The IRA Financial Trust Company, a self-directed IRA custodian, was founded by Adam Bergman, a partner with the IRA Financial Group. Mr. Bergman is a leading expert on the taxation of retirement funds and has authored multiples articles on how to use a self-directed IRA to buy cryptocurrencies.

Adam Bergman, IRA Financial Group partner, has written seven books on the topic of self-directed retirement plans, including, “How to use Retirement Funds to Purchase Cryptocurrencies,” “Turning Retirement Funds into Start-Up Dreams,” “Solo 401(k) Plan in a Nutshell,” and “In God We Trust in Roth We Prosper.”

To learn more about the IRA Financial Group please visit their website at http://www.irafinancialgroup.com or call 800-472-0646.

Share article on social media or email:

Rocke Andrews Named President of NAMB – New Campaign Unveiled “NAMB FOR ALL”


“It’s time to remember that NAMB is for its members. Not one group or another. NAMB is for all its members. And the core purpose and mission that NAMB set in 1973 is more important than ever today. Prosperity for all,” said NAMB President Rocke Andrews in his inaugural speech at NAMB National 2019.

National Association of Mortgage Brokers (NAMB) inaugurates Rocke Andrews at NAMB National 2019 conference. Andrews replaces Rick Bettencourt.

Andrews, broker/owner of Lending Arizona, has served in several high-profile positions at NAMB, including serving as NAMB President in 2015.

“Rocke has been an active member, volunteer and leader of NAMB for more than 20 years,” said outgoing NAMB President Rick Bettencourt. “NAMB has huge momentum right now as our industry accelerates. Rocke brings great leadership to our diverse member-base and unites our industry.”

In a powerful inaugural speech that kicked off NAMB National 2019 in Las Vegas Saturday, September 14, 2019, the largest attended conference in the industry, Andrews made a compelling call to members.

“It’s time to remember that NAMB is for its members. Not one group or another. NAMB is for all its members. And the core purpose and mission that NAMB set in 1973 is more important than ever today. Prosperity for all,” said NAMB President Rocke Andrews in his inaugural speech at NAMB National 2019 in Las Vegas.

Andrews unveiled a new campaign that he explains reasserts NAMB’s industry leadership and core purpose when it was formed by members and for members in 1973. NAMB FOR ALL drives awareness of the significant tools, education and advocacy that NAMB delivers to its members and the industry at-large.

NAMB has been actively lobbying for mortgage professionals for the past 27 years. They’ve contributed to seismic changes in the industry including weighing in on the Dodd-Frank legislation, initiating the SAFE Act that was signed into law in 2008, and writing the model state initiative which was eventually adopted by NMLS. NAMB and its predominantly volunteer-based leadership team continues to build on the milestone accomplishments it has made for the greater part of its 46-year history.

Andrews asked members to come together, “My commitment to you as incoming president is that I will reach out regularly to understand your pain points and where we can help alleviate them. I will always keep you apprised of all the initiatives taking place, but I have one ask. Be an active member. NAMB is a member-based, volunteer association. We need to hear from you. We need you getting involved. We need everyone working together. NAMB for All!”

ABOUT NAMB:

The National Association of Mortgage Brokers is the voice of the mortgage industry representing the interests of mortgage professionals and homebuyers since 1973. NAMB members include small business owners, loan originators, account executives, and other industry professionals. NAMB provides mortgage professionals with advocacy, education opportunities and offers rigorous certification programs to recognize members with the highest levels of professional knowledge and education. NAMB’s active lobbying and advocacy efforts focus on national and state issues, protecting the interests of its members and borrowers. As the leading national trade association for the mortgage industry, NAMB is affiliated with State Associations throughout the country and represents the interests of more than 910,000* licensed and registered Mortgage Loan Originators and 39,000* licensed mortgage broker and mortgage lender businesses. The Association hosts several meetings throughout the year. For more information, please visit NAMB FOR ALL.

Share article on social media or email:

Dental Intelligence, Inc. Announces $34 Million in Series A Funding from K1 Investment Management


News Image

This significant investment will accelerate di.’s ability to continue developing new tools so that providers can perform better dentistry and do more of it. K1’s strong operational capabilities and track record of building category leaders made them a perfect partner for us. Weston Lunsford, CEO

Dental Intelligence, Inc., the leading analytics and workflow automation platform for dental practices, announced today that it has raised a $34 million minority Series A growth round of funding from K1 Investment Management, a leading investment firm focusing on high-growth enterprise software companies.

Dental Intelligence (“di.”) launched in 2015 as a product to help dentists manage and grow their practices. Since then, the company has developed additional patient-focused applications driven by sophisticated analytics, including the Patient Finder, Morning Huddle, and Today’s Follow-Ups. In less than four years’ time, di.’s platform has been adopted by over 5,000 dental practices across the U.S., which have seen an average increase in topline production of over 50% after the first 12 months of usage.

“This investment marks a big milestone in di.’s growth,” said Weston Lunsford, co-founder and CEO of Dental Intelligence. “From the beginning, our company has had one simple purpose: helping dentists improve team performance, value, and overall culture in the practice. Everything we do emanates emotion, inspires engagement, and enables enrichment around that one purpose. This significant investment will accelerate di.’s ability to continue developing new tools so that providers can perform better dentistry and do more of it. K1’s strong operational capabilities and track record of building category leaders made them a perfect partner for us.”

A portion of the funding was used toward the recent acquisition of LocalMed, the industry leader in providing real-time, online appointment scheduling. Dental Intelligence will also use the investment to further develop and market existing and future products to individual, small group, and large enterprise practices due to increased demand across all customer segments.

“We are thrilled to partner with Weston and the Dental Intelligence team in this next chapter of growth and to support their mission of improving patient care,” said Kellen Haines, Vice President at K1. “Providing dentists with increased visibility into the performance of their practices and giving them the tools to be more successful in driving additional care is a win-win.”

In just over four years, Dental Intelligence has grown to over 150 team members with plans to bring on additional new hires throughout the company over 2019 and 2020.

“Dental Intelligence has experienced incredible revenue growth, having more than doubled since our initial underwriting,” added Taylor Beaupain, Managing Partner at K1 Investment Management. “K1’s investment, along with the company’s recent appointment to the Inc 5000 list of fastest-growing companies and the Utah Business Fast 50, provide continued recognition and validation of the company’s efforts to improve the lives and practices of dentists across the country.”

About Dental Intelligence

Dental Intelligence is the world’s smartest software used by thousands of dentists to manage and grow their practices. Dental Intelligence simplifies the team’s daily activities that are most important in improving patient health and increasing profitability in the practice. To learn more, visit http://www.dentalintel.com/

About LocalMed

LocalMed’s real-time online scheduling platform helps dental practices close the loop on all of their marketing efforts by connecting with potential patients wherever they’re searching: a practice’s website, Google, social media, insurance and product partners, etc. With LocalMed, a dental practice is open for scheduling anywhere, anytime, 24/7. Visit http://localmed.com to learn more.

About K1

K1 builds category-leading enterprise software companies. As a global investment firm, K1 assists high-growth businesses to achieve successful outcomes. K1 invests alongside strong management teams that continue to guide their organizations on a day-to-day basis. With over 85 professionals, K1 changes industry landscapes by assisting with operationally-focused growth strategies. Since the inception of the firm, K1 has partnered with over 110 enterprise software companies including industry leaders such as Apttus, Buildium, Certify, Checkmarx, ChiroTouch, Chrome River, Clarizen, ControlUp, Granicus, IronScales, Jobvite, Onit, Rave Mobile Safety, RFPIO, Smarsh and WorkForce Software. For more information about K1, please visit http://www.k1capital.com or http://www.linkedin.com/company/k1im.

Share article on social media or email:

Saving the Second Amendment for Those Accused of Domestic Violence


I applaud the Nevada Supreme Court for unanimously doing the right thing

Since 1861 when Nevada became a state, no one accused of misdemeanor battery constituting domestic battery ever had a Sixth Amendment right to a jury trial because the offense was “petty” – meaning the maximum term of jail was 6 months. Under the law, Nevadans didn’t have the right to a jury trial because this offense was deemed “petty”.

How could these be a “petty” offense when Nevadans lose their Second Amendment right for life based solely on the decision of one judge and not a jury of his or her peers?

On September 12, 2019, Michael D. Pariente, Esq. changed that by convincing a unanimous Nevada Supreme Court that this was wrong – that every person in Nevada charged with misdemeanor battery constituting domestic violence must now be given a jury trial.

To read more and Pariente Law Firm, P.C. and read the full opinion of the Court you can visit our blog here

Advanced Opinion from the Nevada Supreme Court can be found on the Nevada Supreme Court website:

75208 – Andersen v. Eighth Jud. Dist. Ct.

Share article on social media or email:

University Hospital Salzburg Selects IntraOp® Mobetron®


Prelude®, Sightline™, Mobetron®

Image-Guided Electron Therapy

We consider Mobetron as a perfect platform for further development of our IORT program and to implement image guided 3D treatment planning.

IntraOp Medical Corporation announced today that University Hospital Salzburg (SALK) Austria has purchased the IntraOp’s third generation Mobetron and advanced treatment planning software, to pursue implementing Image Guided Electron Therapy (IGET) for intraoperative radiation therapy (IORT) clinically.

The Paracelsus Medical University Hospital Salzburg has been a pioneering thought leader in IORT for more than 20 years. Professor Felix Sedlmayer, head of radiation oncology and president of the International Society of IORT (ISIORT) said: “We consider Mobetron as a perfect platform for further development of our IORT program and to implement image guided 3D treatment planning.”

Prof. Sedlmayer is the Principal Investigator in the ongoing HIOB trial (Hypofractionated Whole-Breast Irradiation preceded by Intra-Operative Radiotherapy with Electrons as anticipated Boost). HIOB is the largest prospective multi-institutional trial studying the benefits of electron IORT in the treatment of breast cancer.

“We are delighted to be partnering with Professor Sedlmayer and the team at University Hospital Salzburg and providing the most advanced IORT technology available today,” said Derek T. DeScioli, Chief Executive Officer of IntraOp Medical Corporation. “Their institution has been a pioneer in IORT from the beginning, and we look forward to working with them to advance the research and technology to the next level of sophistication.”

IntraOp will be providing to University Hospital Salzburg its third generation Mobetron technology including automatic soft docking, Prelude® IORT Management system and Radiance® 3D treatment planning as well high density radiotranslucent applicators compatible with Image Guided Electron Therapy.

About IntraOp Medical Corporation

IntraOp® is the leading innovator of electron radiation devices for treating cancer as an adjunct to invasive surgical procedures. As the developer and manufacturer of Mobetron®, IntraOp pioneered the world’s first portable, self-shielded LINAC used for electron-based Intraoperative Radiation Therapy (IORT). Over 20,000 patients in 16 countries have benefited from Mobetron IORT. Based in Sunnyvale, California, IntraOp is a cancer care company uniting radiation and surgical oncology in the fight against cancer. For more information, please visit https://intraop.com.

Product photography available upon request.

Share article on social media or email:

Damo Consulting Releases 2019 Mid-Year “WITCH Report” Of Healthcare IT Consulting Firms


Damo Consulting, a leading digital transformation and growth strategy consultancy for healthcare enterprises and technology firms, today announced the release of its mid-year WITCH Report, which provides a market landscape view of the major global technology consulting firms in healthcare and life sciences. The findings indicate declining growth in the healthcare business of the major global technology firms, but more promising growth within life sciences areas.

The one-of-a-kind WITCH Report, which has been published since 2015, includes a comprehensive review of the financial and market performance of 12 global technology consulting firms in healthcare and life sciences. It provides a detailed review of market performance metrics, insights, and activities of Wipro, Infosys, TCS, Cognizant Technology Solutions, and HCL (WITCH), along with other industry leaders. Information covered in the WITCH Report includes financial performance, M&A activities, customer wins, partnerships, new product initiatives, and leadership announcements.

“Our mid-year review of 12 global technology consulting firms indicates declining growth rates in the past two quarters due to a variety of factors for most of the firms. Large-scale M&A in the health insurance industry, notably CVS-Aetna and Cigna-Express Scripts, has created pricing pressures and related challenges for some firms,” said Paddy Padmanabhan, CEO of Damo Consulting and author of The Big Unlock: Harnessing Data and Growing Digital Businesses in a Value-Based Era.

“In the payer space, several clients of technology providers are in-sourcing their operations which leads to further pressures on topline growth for firms with large exposure to this sector. At the same time, cost pressures faced by clients have resulted in demand slowdown for the short term. The life sciences segment seems to have done better as compared to the healthcare segment for most firms, with one firm being an exception. In terms of deal wins, publicly announced transactions were few.”

A challenge for many of the firms covered in the report is increased levels of H1B visa rejections which create pressures on hiring and margins for onsite client engagements. The ongoing opioid lawsuits could impact overall IT spend by Pharma companies facing monetary penalties, which in turn will impact consulting firms with exposure to these companies.

Compiled from publicly available information, the WITCH Report is a complimentary report that provides the most comprehensive overview of the healthcare market performance of the major global technology consulting firms. In addition to the WITCH companies, the report covers Accenture, Atos, Capgemini, DXC Technology, IBM, and NTT Data, Optum, and Deloitte.

To download the report, visit: https://www.damoconsulting.net/the-witch-report-2019-mid-year-review/

About Damo Consulting

Damo Consulting is a growth strategy and digital transformation advisory firm that works with healthcare enterprises and global technology companies. We help develop and implement digital transformation strategies and enable market growth strategies. We specialize in thought leadership led brand transformation and actionable healthcare market intelligence.

For media inquiries, write to us at info@damoconsulting.net

Share article on social media or email:

CHASM Advanced Materials Partners with Screentec to Offer Transparent Printed Electronics Throughout Europe


CHASM Advanced Materials

CHASM Advanced Materials

“When security or safety of passengers is at risk or patients’ lives are in the balance, the optoelectronic performance and environmental stability of CHASM’s AgeNT™ provides Screentec an ideal platform for electronics that work reliably the first time, every time,” said David Arthur, CEO of CHASM.

CHASM Advanced Materials, the exclusive developer and manufacturer of carbon nanotube (CNT) hybrid transparent conductive films, announced today that it has entered into a partnership with Screentec, a leader in the printed electronics field. This partnership agreement via CHASM’s Preferred Integration Partner Program will draw on the strengths of Screentec’s skilled team of printed electronics experts and CHASM’s boundary pushing CNT Hybrid platform, AgeNT™.

As technology accelerates, product designers and engineers require new, advanced materials that enable their dreams to become reality. With AgeNT transparent conductive films available exclusively from CHASM, product designers and engineers can innovate next generation products unbounded by traditional electronics. Applications of AgeNT include transparent heaters for automotive headlights as well as resistive touch screens for appliances, both of which Screentec will be demonstrating live in Stand E119 at the Alihankinta Subcontracting Fair in Finland September 24-26, 2019.

“Our customers value the high-quality and innovative solutions we develop for user interfaces used in demanding environments, disposable medical electrodes and sensors,” said Mikko Paakkolanvaara, Chief Technology Officer at Screentec. “Adding CHASM’s AgeNT platform to our capabilities expands our resources and enables us to successfully develop new and innovative applications for more clients across industries such as healthcare, automotive and heavy industry.”

“We are delighted to welcome Screentec into our Preferred Integration Partner Program,” said David Arthur, CEO of CHASM. “Screentec’s unique expertise in developing and manufacturing flexible printed electronics in which wear resistance and reliability are a must makes them a distinct addition to our PIP program. When security or safety of passengers is at risk or patients’ lives are in the balance, the optoelectronic performance and environmental stability of CHASM’s AgeNT provides Screentec an ideal platform for electronics that work reliably the first time, every time.”

Membership in the CHASM PIP is offered exclusively to companies not just having an established customer base for flexible printed electronics but also those demonstrating leading expertise at integrating flexible printed electronics into finished product or electronic assemblies. PIP member companies represent the “go-to” companies in the industry, offering their customers extensive integration capabilities and consultative expertise on the latest innovations.

About CHASM Advanced Materials

CHASM Advanced Materials is revolutionizing design and fabrication of printed electronics and energy storage devices through exclusive development and manufacture of CNT hybrid transparent conductive films and CNT hybrid electrode materials. The company’s line of AgeNT transparent conductive films is flexible and formable with low pattering costs and low sheet resistance at high transparency. Leading companies across multiple industries have successfully launched next generation innovations using transparent circuits, heaters, antennas, and films as well as advanced CNT inks and carbon nanotubes (CNTs) only available from CHASM. For more information, visit http://www.chasmtek.com or follow us: @CHASMAdvanced, LinkedIn, Instagram, and Facebook.

For more information on becoming a CHASM Preferred Integration Partner, click here, contact sales@chasmtek.com or call +1.781.821.0443.

About Screentec

Screentec is a leading contract manufacturer in the field of printed electronics in demanding environments where devices must work the first time, every time. The company provides innovative and cutting-edge solutions in the field of user interfaces, disposable medical electrodes and sensor applications serving international customers in the medical, automotive and transport industries, among others. Screentec’s customers have come to rely on the company’s flexible production methods to ensure their product’s success. Learn more on our website at http://www.screentec.com or connect with us on LinkedIn.

Share article on social media or email:



Press Release News Wire Service